|
Vaccine Detail
Mycobacterium tuberculosis sigE mutant vaccine |
Vaccine Information |
- Vaccine Name: Mycobacterium tuberculosis sigE mutant vaccine
- Target Pathogen: Mycobacterium tuberculosis
- Target Disease: Tuberculosis
- Vaccine Ontology ID: VO_0002795
- Type: Live, attenuated vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse
- sigE
gene engineering:
- Type: Gene mutation
- Description: This sigE mutant is from Mycobacterium tuberculosis (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Immunization Route: Intratracheal immunization
|
Host Response |
Mouse Response
- Persistence: A sigE mutant is attenuated in mice (Hernandez et al., 2010).
- Efficacy: A sigE mutant induces significant protection in mice from challenge with wild type M. tuberculosis (Hernandez et al., 2010).
- Host Defb3 response
- Description: A sigE mutant showed a significantly higher and constant expression of the gene encoding β-defensin 3 in the lungs beginning the 7th day post vaccination until the 28th day as compared to mice infected with the parental strain (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Host Ifng (Interferon gamma) response
- Description: A sigE mutant showed a significantly higher and constant expression of the gene encoding IFN-γ as compared to mice infected with the parental strain. IFN-gamma was significantly upregulated in mice lungs after vaccination with the mutant as compared to infection with the wild type beginning day 1 post-infection and continuing throughout the duration of the experiment (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Host Il10 (interleukin 10) response
- Description: The expression of IL-10 was higher in sigE mutant-infected mice lungs as compared to infection with the parental strain, but it was significant only 21 and 28 days after the infection (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Host Il4 (interleukin 4) response
- Description: IL-4 was expressed at a significantly lower level in the sigE mutant-infected mice as compared to mice infected with the wild type pathogen. Significant down regulation of IL-4 by the mutant in mouse lungs was seen days 1-28 post infection as compared to infection with the wild type (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Host TNF-alpha response
- Description: A sigE mutant showed a significantly higher and constant expression of the gene encoding TNF-alpha as compared to mice infected with the parental strain. Vaccination with the mutant significantly up-regulated TNF-alpha in mice lungs on days 1, 21, and 28 post-infection as compared to infection with the wild type (Hernandez et al., 2010).
- Detailed Gene Information: Click Here.
- Information about this animal model: Mouse Model for TB research
Human Response
- Description: The human monocytic cell line THP-1 was obtained from the ATCC, and cultures were grown (Fontán et al., 2008).
- Host APOBEC3B response
- Description: A sigE mutant upregulates APOBEC3B in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host C19orf66 response
- Description: A sigE mutant upregulates C19orf66 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host CD70 response
- Description: A sigE mutant upregulates CD70 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host GPR182 response
- Description: A sigE mutant upregulates GPR182 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host HIST1H2BE response
- Description: A sigE mutant upregulates HIST1H2BE in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host HIST2H4A response
- Description: A sigE mutant upregulates HIST2H4A in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host PCDHB1 response
- Description: A sigE mutant upregulates PCDHB1 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host PTCD1 response
- Description: A sigE mutant upregulates PTCD1 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host STAG3 response
- Description: A sigE mutant upregulates STAG3 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host TBX21 response
- Description: A sigE mutant upregulates TBX21 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
- Host TSC22D4 response
- Description: A sigE mutant upregulates TSC22D4 in human THP-1 cells, which was not significantly upregulated after infection with the wild type pathogen (Fontán et al., 2008).
- Detailed Gene Information: Click Here.
|
References |
Fontán et al., 2008: Fontán PA, Aris V, Alvarez ME, Ghanny S, Cheng J, Soteropoulos P, Trevani A, Pine R, Smith I. Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response. The Journal of infectious diseases. 2008; 198(6); 877-885. [PubMed: 18657035].
Hernandez et al., 2010: Hernandez Pando R, Aguilar LD, Smith I, Manganelli R. Immunogenicity and protection induced by a Mycobacterium tuberculosis sigE mutant in a BALB/c mouse model of progressive pulmonary tuberculosis. Infection and immunity. 2010; 78(7); 3168-3176. [PubMed: 20457786].
|
|